Duopharma Biotech Bhd Group of Companies
Duopharma Biotech Bhd posted a 6 increase in net profit for the second quarter ended June 30 2022 to RM1631 million from RM1539 million a year earlier underpinned by a higher revenue. Its quarterly revenue jumped by nearly 17 to RM18174 million from RM15544 million fuelled by higher sales to the ethical classic market and public health.
Duopharma Biotech Berhad Linkedin

Ccm Duopharma Biotech Gets Approval For New Drug The Edge Markets
Homepage Duopharma Biotech Berhad
Duopharma Biotech Berhad Linkedin
Duopharma Biotech Invests A Total Of Us 500 000 Into Naluri S Series A Funding Round Businesstoday
No comments for "Duopharma Biotech Bhd Group of Companies"
Post a Comment